Schedule 13G ownership disclosure
COGENT BIOSCIENCES INC
Common Stock, par value $0.001 · CUSIP: 19240Q201
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Kynam Capital Management, LP
Shares: 6,165,223 · Class: 4.33%
- Kynam Capital Management GP, LLC
Shares: 6,165,223 · Class: 4.33%
- Yue Tang
Shares: 6,165,223 · Class: 4.33%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001907884-26-000002
- Form type
- SCHEDULE 13G/A
- Filer
- Cogent Biosciences, Inc.
- CIK
- CIK 1622229
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership